Whole-Body [18F]FDG PET/CT Can Alter Diagnosis in Patients with Suspected Rheumatic Disease

التفاصيل البيبلوغرافية
العنوان: Whole-Body [18F]FDG PET/CT Can Alter Diagnosis in Patients with Suspected Rheumatic Disease
المؤلفون: Fröhlich, Matthias, Serfling, Sebastian, Higuchi, Takahiro, Pomper, Martin G., Rowe, Steven P., Schmalzing, Marc, Tony, Hans-Peter, Gernert, Michael, Strunz, Patrick-Pascal, Portegys, Jan, Schwaneck, Eva-Christina, Gadeholt, Ottar, Weich, Alexander, Buck, Andreas K., Bley, Thorsten A., Guggenberger, Konstanze V., Werner, Rudolf A.
المصدر: Diagnostics, Vol 11, Iss 2073, p 2073 (2021)
بيانات النشر: MDPI AG, 2021.
سنة النشر: 2021
مصطلحات موضوعية: musculoskeletal diseases, Medicine (General), vasculature, R5-920, giant cell arteritis, inflammation, GCA, ddc:610, [18F]FDG PET/CT, polymyalgia rheumatica
الوصف: The 2-deoxy-d-[18F]fluoro-D-glucose (FDG) positron emission tomography/computed tomography (PET/CT) is widely utilized to assess the vascular and articular inflammatory burden of patients with a suspected diagnosis of rheumatic disease. We aimed to elucidate the impact of [18F]FDG PET/CT on change in initially suspected diagnosis in patients at the time of the scan. Thirty-four patients, who had undergone [18F]FDG PET/CT, were enrolled and the initially suspected diagnosis prior to [18F]FDG PET/CT was compared to the final diagnosis. In addition, a semi-quantitative analysis including vessel wall-to-liver (VLR) and joint-to-liver (JLR) ratios was also conducted. Prior to [18F]FDG PET/CT, 22/34 (64.7%) of patients did not have an established diagnosis, whereas in 7/34 (20.6%), polymyalgia rheumatica (PMR) was suspected, and in 5/34 (14.7%), giant cell arteritis (GCA) was suspected by the referring rheumatologists. After [18F]FDG PET/CT, the diagnosis was GCA in 19/34 (55.9%), combined GCA and PMR (GCA + PMR) in 9/34 (26.5%) and PMR in the remaining 6/34 (17.6%). As such, [18F]FDG PET/CT altered suspected diagnosis in 28/34 (82.4%), including in all unclear cases. VLR of patients whose final diagnosis was GCA tended to be significantly higher when compared to VLR in PMR (GCA, 1.01 ± 0.08 (95%CI, 0.95–1.1) vs. PMR, 0.92 ± 0.1 (95%CI, 0.85–0.99), p = 0.07), but not when compared to PMR + GCA (1.04 ± 0.14 (95%CI, 0.95–1.13), p = 1). JLR of individuals finally diagnosed with PMR (0.94 ± 0.16, (95%CI, 0.83–1.06)), however, was significantly increased relative to JLR in GCA (0.58 ± 0.04 (95%CI, 0.55–0.61)) and GCA + PMR (0.64 ± 0.09 (95%CI, 0.57–0.71); p < 0.0001, respectively). In individuals with a suspected diagnosis of rheumatic disease, an inflammatory-directed [18F]FDG PET/CT can alter diagnosis in the majority of the cases, particularly in subjects who were referred because of diagnostic uncertainty. Semi-quantitative assessment may be helpful in establishing a final diagnosis of PMR, supporting the notion that a quantitative whole-body read-out may be useful in unclear cases.
وصف الملف: application/pdf
اللغة: English
تدمد: 2075-4418
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::69f4694cf3613b86f0fe1f91a6876ae7Test
https://www.mdpi.com/2075-4418/11/11/2073Test
حقوق: OPEN
رقم الانضمام: edsair.dedup.wf.001..69f4694cf3613b86f0fe1f91a6876ae7
قاعدة البيانات: OpenAIRE